AUGUST ANNOUNCEMENTS
Race is now at the forefront of conversations at academic health centers across the country. Faculty members, staff, and students alike are wrestling with difficult questions about the role that racial categories play in biomedical science and the delivery of care. Hear how six health care experts grapple with how to address race without being racist. [read more]
feature
When Larry Fong, MD, started his career in medicine, immunotherapy was considered science fiction. Today, immunotherapy is a key frontier in cancer treatment, and Fong, a recognized leader in the field, holds one of the NCI’s most competitive awards.
feature
The program aims to foster the development of the next generation of clinical scientists to be effective partners with discovery scientists and conduct high impact and innovative patient-centered cancer research. Apply by December 3, 2021.
Job Opportunity
jobs
The Helen Diller Family Comprehensive Cancer Center is seeking a Director of Scientific Programs for the Living Therapeutics Initiative. Please share this opportunity with your networks.

Welcome New Members
Joaquin Anguera, PhD – Associate Member, Pediatric Malignancies

Bridget Keenan, MD, PhD – Associate Member, Cancer Immunology & Immunotherapy

Anya Levinson, MD – Associate Member, Pediatric Malignancies

Jennifer Rosenbluth, MD, PhD – Member, Breast Oncology
Awards & Distinctions
Jennifer Rosenbluth, MD, PhD received a 2021 Clinical Scientist Development Award from the Doris Duke Charitable Foundation for a project, "Reversion of Aging-Associated Cell Lineage Changes in the Breast for Cancer Prevention."

Lawrence Fong, MD received an NCI Outstanding Investigator Award (R35) for a project, "Determinants of response to cancer immunotherapy."

The TRANSPERS Center was awarded a 5-year grant from the National Human Genomic Research Institute (NHGRI/NIH) to examine coverage and value for two types of emerging genomic tests. Learn more.

UCSF Medical Center ranked among the nation's 10 best hospitals, and first nationwide for neurology and neurosurgery, in the 2021-2022 U.S. News & World Report Best Hospitals Survey. Learn more.
In the News
Recent Publications
DeRouen MC, Canchola AJ, Thompson CA, Jin A, Nie S, Wong C, Lichtensztajn D, Allen L, Patel MI, Daida YG, Luft HS, Shariff-Marco S, Reynolds P, Wakelee HA, Liang SY, Waitzfelder BE, Cheng I, Gomez SL. Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females. J Natl Cancer Inst. 2021 Aug 4:djab143.

Das R, Sjöström M, Shrestha R, Yogodzinski C, Egusa EA, Chesner LN, Chen WS, Chou J, Dang DK, Swinderman JT, Ge A, Hua JT, Kabir S, Quigley DA, Small EJ, Ashworth A, Feng FY, Gilbert LA. An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer. Nat Commun. 2021 Jul 29;12(1):4601.

Wu J, Gupta R, Barreto J, Doo P, Joseph NM, Lee JC, Perry A, Chang SM, Berger MS, Solomon DA. Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasia. Neuro Oncol. 2021 Aug 5:noab157.

Education & Training
HDFCCC F Grant Writing Workshop (F31s & F32s)
Oct 2021 – Mar 2022

This workshop is for graduate students and postdocs who plan on submitting an F31 or F32 for the April 2022 deadline. Participants will attend monthly virtual lectures covering different sections of the grant, write a draft, receive peer and mentor review, and learn about the grant submission process.
 
training
Community Engagement
Saturday, Sept 11 | 9:00 am - 12:30 pm

Engage, equip, network, and partner to take action for healthier individuals, congregations, and communities with sustainable responses to address health disparities. Learn more.
community
Featured Tweet
Upcoming Events
Mark O'Hara, MD, will present, "CAR T cell combination strategies in pancreatic cancer."

Thea Tlsty, PhD, will present, "Cellular conversations that control cancer."

Join us for a virtual event benefitting the Lazarex Cancer Foundation.

A meeting focused on cancer genomics and computational cancer biology and oncology.